Our grant programs aim to advance geroscience globally across the entire R&D value chain, through funding long-term basic research; accelerating new drug development; expanding therapeutic applications of existing drugs and, over time, ensuring that innovations in age-related science and medicine are accessible to everyone worldwide.
This work has four goals:
Drive the development of tools, technologies, and new drugs, to make aging healthier
Identify and support new talent in healthspan science
Promote constructive scientific competition that encourages breakthrough innovations
Raise awareness and support policymaking and regulation that enables aging-related science